← back to search

David Uehling

Hospital for Sick Children · CA
Area of research
Molecular Biology · Organic Chemistry
Research interest
Research interests include Medicine, Kinase, Cancer research, Venetoclax, Chronic lymphocytic leukemia, and Disulfiram.
h-index
citations
377
works
5
NIH funding
primary concept
email

Recent publications

The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia
OncoImmunology 2021cited by 10position: middledoi
The PKN1- TRAF1 signaling axis as a potential new target for chronic lymphocytic leukemia
medRxiv 2021cited by 0position: middledoi
Functional characterization of a PROTAC directed against BRAF mutant V600E
Nature Chemical Biology 2020cited by 130position: middledoi
A drug discovery platform to identify compounds that inhibit EGFR triple mutants
Nature Chemical Biology 2020cited by 38position: middledoi
Disulfiram when Combined with Copper Enhances the Therapeutic Effects of Temozolomide for the Treatment of Glioblastoma
Clinical Cancer Research 2016cited by 199position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

· 2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2021–2021) · 2 papers (2021–2021)Andrea Arruda · Research Canada2 papers (2021–2021)Safoura Zangiabadi · York University2 papers (2021–2021) · 2 papers (2021–2021)Achire N. Mbanwi · Queen's University2 papers (2021–2021)Mark D. Minden · Toronto Public Health2 papers (2021–2021)Ali A. Abdul‐Sater · Columbia University2 papers (2021–2021)Rima Al‐awar · Ontario Institute for Cancer Research2 papers (2021–2021)Natalie Grinshtein · Patheon (Canada)1 papers (2016–2016)Jeffrey L. Wrana · St Michael's Hospital1 papers (2016–2016)J. Gregory Cairncross · University of Calgary1 papers (2016–2016)Ahmed Aman · Ontario Institute for Cancer Research1 papers (2016–2016)Artee Luchman · University of Calgary1 papers (2016–2016)Stephen M. Robbins · Jewish General Hospital1 papers (2016–2016)Jennifer C. King · Go2 for Lung Cancer1 papers (2016–2016)Samuel Weiss · University of Calgary1 papers (2016–2016)